课题基金 / 基金详情

Development of novel inhibitors of interstrand cross-link repair to combat chemoresistance in ovarian cancer

Development of novel inhibitors of interstrand cross-link repair to combat chemoresistance in ovarian cancer
开发新型链间交联修复抑制剂以对抗卵巢癌的化疗耐药性
批准号：
364853
负责人：
Grainger Ryan A
金额：
$0.07万
依托单位：
University of Western Ontario
依托单位国家：
加拿大
项目类别：
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-01-01 至 2018-01-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=364853&lang=en
关键词：
Ics Travel Awards

项目摘要

项目成果

Grainger Ryan A的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the most common treatments for ovarian, colon and lung cancers is chemotherapy that induces a kind of DNA damage known as interstrand crosslinks (ICLs). Though these chemotherapies tend to be successful when initially used, they often lead to the d
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using novel inhibitors of interstrand cross-link repair to sensitize chemo-resistant cancer cell lines
  • 批准号：
    351200
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2015
  • 负责人：
    Grainger Ryan A
  • 依托单位：
    University of Western Ontario